Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

Gracell Biotechnologies (NASDAQ: GRCL) announced its participation in three investor conferences in June 2022, focused on advancing its innovative cell therapies for cancer treatment. Events include the Goldman Sachs Virtual Healthcare Corporate Day from June 20-24, the Truist Securities Cell Therapy Symposium in New York on June 28, and the Stifel 2022 Virtual Cell Therapy Summit panel discussion on June 30 at 11:30 am ET. Gracell aims to leverage its FasTCAR and TruUCAR technologies to improve CAR-T therapy outcomes, addressing challenges like manufacturing time and costs.

SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, June. 14, 2022  /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three investor conferences in June 2022 as follows:

Goldman Sachs Virtual Healthcare Corporate Day

One-on-one meetings: June 20 - 24

Truist Securities Cell Therapy Symposium - symposia-cel (in person)

One-on-one meetings: June 28
Location: New York, NY

Stifel 2022 Virtual Cell Therapy Summit

Panel: June 30 at 11:30 am ET
Corporate Panel: Allogeneic CAR-T – What Have We Learned, and Where are We Going

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CART^TM technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com. Follow @GracellBio on LinkedIn.

Media contact
Marvin Tang
marvin.tang@gracellbio.com

Investor contact
Gracie Tong 
gracie.tong@gracellbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-301567117.html

SOURCE Gracell Biotechnologies Inc.

FAQ

What conferences will Gracell participate in June 2022?

Gracell will participate in the Goldman Sachs Virtual Healthcare Corporate Day, Truist Securities Cell Therapy Symposium, and Stifel 2022 Virtual Cell Therapy Summit.

When is the Goldman Sachs Virtual Healthcare Corporate Day for Gracell?

The Goldman Sachs Virtual Healthcare Corporate Day will take place from June 20-24, 2022.

Where will the Truist Securities Cell Therapy Symposium be held?

The Truist Securities Cell Therapy Symposium will be held in New York on June 28, 2022.

What is the date and time of the Stifel 2022 Virtual Cell Therapy Summit panel?

The Stifel 2022 Virtual Cell Therapy Summit panel will occur on June 30, 2022, at 11:30 am ET.

What technologies does Gracell use for developing cell therapies?

Gracell uses FasTCAR, TruUCAR, and SMART CART technologies to develop its cell therapies.